This month we hear from Kamisha Johnson-Davis, whom we welcome as the new chair of the Communications Committee. Kamisha is joined by Ofelia Noceti as vice-chair.

Best wishes to the committee who continue the wonderful work of Denise McKeown and Maria Shipkova.

Kamisha Johnson-Davis
Associate Professor (Clinical), Department of Pathology, University of Utah

Medical Director, Clinical Toxicology, ARUP Laboratories

Salt Lake City, Utah, USA

This month we hear from Jiangtao Tang from the West China Hospital, who shares about the challenges they are overcoming at his centre switching from immunoassay to mass spectrometry based assays and automation of sample pre-processing.  Jiangtao further shares his vision how metabolomics and proteomics, together with bioinformatics, will optimize patient care.

Jiangtao Tang
Department of Clinical Immunological Laboratory, West China Hospital

Sichuan University, Chengdu, CN

This month our current President, Teun van Gelder, shares his vision for his term, in particular increasing involvement of prescribers with the activities of the Association and research in the field. We also hear about Teun’s dual role at the Erasmus Medical Centre, and the collaboration between several prominent IATDMCT members that bring together various disciplines to daily patient care.

Teun van Gelder
Internist-nephrologist, Department of Internal Medicine
Internist-clinical pharmacologist, Hospital Pharmacy Department
Erasmus Medical Center, Rotterdam, NL

This month we hear from our recent Past-President, Loralie Langman, who shares with us a few reflections about her time as President, her passion for the field and a few innovative technologies used in her place of practice, spanning clinical and forensic toxicology, TDM, and pharmacogenetics.

Loralie Langman
Director, Department of Laboratory Medicine and Pathology
Mayo Clinic, Rochester, MN, USA